Ciming Boao International Hospital is a hospital inside the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, and is named on the official July 2026 Lecheng register of 58 biomedical new technologies as the designated delivering hospital for six of them — all on the stem cell line. For patients outside China researching regenerative-medicine options, this is a hospital whose scope can be checked against a public register rather than a marketing page. Whether any specific technology is appropriate for your situation is a clinical decision made by the treating physician after assessment; China Care helps you work out whether it is worth pursuing before you travel.
The Boao Lecheng International Medical Tourism Pilot Zone operates under a separate national policy framework from mainland Chinese hospitals. Hospitals licensed inside the zone may deliver designated new biomedical technologies, and may also use drugs and medical devices approved by the US FDA, the EMA or Japan's PMDA before they receive NMPA approval in mainland China — typically two to three years earlier.
Ciming Boao International Hospital sits inside that zone. On the official July 2026 register of 58 biomedical new technologies it is named as the designated delivering hospital for six technologies, all stem cell therapies: allogeneic adipose-derived stem cells for refractory autoimmune disease; bone-marrow mesenchymal stem cells for acute-on-chronic liver failure; umbilical-cord mesenchymal stem cells for type 2 diabetes; umbilical-cord mesenchymal stem cells for premature ovarian insufficiency; stem cell therapy for post-stroke sequelae; and stem cell therapy for refractory immune thrombocytopenia (ITP).
Hainan island also allows visa-free entry for nationals of 59+ countries for stays of up to 30 days, which is a practical difference from reaching mainland Chinese hospitals. For patients considering stem cell therapy in China, Ciming Boao's registered scope is one that can be checked against a published register of technologies rather than a hospital's own brochure.
The July 2026 Lecheng register names Ciming Boao International Hospital as the designated delivering hospital for six technologies, every one of them a stem cell therapy. The registered scope covers refractory autoimmune disease, acute-on-chronic liver failure, type 2 diabetes, premature ovarian insufficiency, post-stroke sequelae and refractory ITP.
Under the Lecheng policy framework, registered technologies may only be delivered at licensed hospitals inside the pilot zone. Ciming Boao is one of those hospitals, which is why its scope can be checked against the official register rather than taken on trust.
The registered items are concentrated in conditions that are chronic, immune-mediated or neurological — areas where patients often arrive having already tried conventional treatment. Eligibility, expected benefit and risks are determined by the treating physician after assessment, and nothing is guaranteed.
Finding a hospital's name is easy. Knowing whether it's actually the right one for your situation is much harder — that's where China Care helps.
Most international patients researching Ciming Boao International Hospital are unsure whether it is genuinely the right fit for their case, or whether another hospital might serve them better. China Care helps you answer questions like:
The July 2026 Lecheng register names the hospital designated to deliver each of the 58 approved technologies. Those below are the ones registered to Ciming Boao International Hospital. Registered scope is not a statement that a technology is right for any individual patient.
Registered scope drawn from the official July 2026 Lecheng register of 58 biomedical new technologies. The register lists each technology and the hospital designated to deliver it; it does not state hospital size, ownership, department structure or physician names, and this page does not claim any. Current availability, requirements and clinical suitability must be confirmed with the hospital.
Finding a hospital is the easy part. Understanding whether it's the right one for your situation is harder — China Care guides you through that, from initial guidance through to on-the-ground support in the Boao Lecheng zone.
Share your diagnosis, pathology, imaging, and any previous treatment records. If you have been advised that a specific technology on the Lecheng register may be relevant, include the name of that technology. This step is free and helps us understand whether Ciming Boao International Hospital — or another hospital — may be worth exploring for your case. China Care prepares a bilingual case summary within 1–2 working days.
records review · 1–2 daysIf it makes sense to go further, Hospital Access looks into whether Ciming Boao International Hospital is genuinely a suitable option for your case — before you commit to travelling. Depending on your situation this may include medical record review, department identification, specialist discussion, and a proxy consultation with the relevant specialist where appropriate. China Care attends Ciming Boao International Hospital in person on your behalf, and where a registered technology is involved the physician confirms eligibility at this stage. The outcome is reported back to you. This is a fixed-fee service, agreed with you upfront.
Already in China or already in Hainan? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
Hospital Access · fixed fee · eligibility confirmedInternational patients from over 59 nationalities can enter Hainan visa-free for up to 30 days. This is a significant practical advantage compared with mainland Chinese hospital access, which requires a formal medical visa. China Care advises you on the applicable entry rules based on your nationality. Fly into Boao Airport or Haikou Meilan International Airport.
visa-free 59+ nationalities · 30-day entryPre-treatment screening — which may include genetic testing or imaging assessment — is required before a treatment plan can be confirmed, and is charged separately. Your in-person specialist consultation then confirms whether treatment proceeds and on what schedule. All treatment fees are paid directly to the hospital in RMB, at the price the hospital sets on the day.
screening charged separately · RMB direct to hospitalTreatment is delivered according to the agreed schedule, which for many registered technologies runs across several infusions over weeks rather than a single visit. After the course, China Care helps arrange an end-of-treatment review, bilingual documentation, and a structured follow-up plan in a format your home clinician can use.
multi-visit course · bilingual documentationWhichever stage you're at, China Care's role is the same: help you make an informed decision, not just a booking.
Records review, specialist matching, and appointment coordination — confirming whether Ciming Boao International Hospital or another hospital is the right fit before you commit to travel.
Learn more →Support before, during, and after treatment in China — including interpretation, escort, and bilingual documentation across a multi-visit course.
Learn more →We'll help you understand whether Ciming Boao International Hospital — or another hospital in China — may be a better option for your situation.
Treatment costs are quoted directly by Ciming Boao International Hospital. We never add to or mark up the hospital's quoted treatment cost. Registered technologies are fully self-paid and deliverable only inside the Lecheng pilot zone.
Hospital profile note: This profile is general reference information. China Care does not endorse or guarantee a particular hospital, treatment, appointment, clinical decision, or outcome. Registered scope is taken from the official July 2026 Lecheng register; current services, requirements, language support, availability, and clinical suitability should be confirmed directly with the hospital.